High Efficiency Cell Engineering Seminar - Hosted at Hiroshima University in Japan

Join us at Hiroshima University for an insightful seminar hosted by MaxCyte

Tuesday, July 16th, 2024
12:00 pm - 1:00 pm (JST)

In-Person Event
Hiroshima University
Research Institute for Radiation Biology and Medicine
1-2-3 Kasumi, Minamiku, Hiroshima 734-8553, Japan

About the seminar

Join us for an exciting cell engineering lunch seminar on Tuesday, July 16th, from 12:00 pm (noon) - 1:00 pm at Hiroshima University!
Register to hear how guest speaker Dr. Steven Feldman, Stanford University's Site Head & the Scientific Director of the Laboratory of Cell & Gene Medicine leverages the MaxCyte platform to manufacture gene engineered products for patients. You will also gain valuable insights into how MaxCyte innovative electroporation platforms enable the efficient engineering of primary cells, stem cells, and many more cell lines. Discover how our technology guarantees high cell viability and optimal recovery rates for a wide range of applications, including CRISPR, cell-based assays, cell therapy manufacturing, viral production, and so much more.

Lunch will be on us: We value your time, and to keep the focus on learning, we're providing a complimentary breakfast for all in-person attendees.

Space is limited so reserve your spot today!


Feldman, Steven-0701

Steven Feldman, PhD

Site Head & Scientific Director of the Laboratory for Cell & Gene Medicine
Stanford Center for Cancer Cell Therapy

Dr. Feldman is part of the Stanford Center for Cancer Cell Therapy and serves as the Site Head and Scientific Director of Stanford's GMP Facility. He has a leadership role and his team at Stanford focuses on the development and manufacture of novel cell therapies for the treatment of cancer.
Picture of Peter Gee

Masahisa Ohishi, PhD

Senior Field Applications Scientist
MaxCyte, Inc.

Peter Gee is a MaxCyte Senior Field Applications Scientist specializing in gene editing and stem cell technologies. After completing a Ph.D. at the Institute for Virus Research, Kyoto University, Peter did his postdoctoral training in the laboratory of Akitsu Hotta at Kyoto University’s Center for iPS Cell Research and Application, where he developed delivery vehicles of CRISPR-Cas9 ribonucleoprotein complexes utilizing engineered extracellular nanoparticles.

Register today

Can't make the in-person event?

Plan to attend the in-person seminar? Fill the form below to register.